Supernus Pharmaceuticals, Inc.
Clinical trials sponsored by Supernus Pharmaceuticals, Inc., explained in plain language.
-
New hope for deadly seizures: experimental drug SAGE-547 tested
Disease control NO_LONGER_AVAILABLEThis study offered SAGE-547, an experimental drug given as a continuous IV infusion, to people aged 6 months and older with super-refractory status epilepticus—a dangerous condition where seizures continue despite standard treatments. The goal was to see if the drug could help co…
Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 26, 2026 16:59 UTC
-
New drug ZULRESSO offers hope for moms with postpartum depression
Symptom relief APPROVED_FOR_MARKETINGThis program provides early access to ZULRESSO (brexanolone) for adult women with postpartum depression before the drug is widely available. Eligible women receive a one-time injection under medical supervision. The goal is to help ease severe depression symptoms quickly.
Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 17:07 UTC